253 related articles for article (PubMed ID: 16036767)
1. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
Moser VC; Walls I; Zoetis T
Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
[TBL] [Abstract][Full Text] [Related]
2. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
[TBL] [Abstract][Full Text] [Related]
3. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
5. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Raffaele KC; Fisher JE; Hancock S; Hazelden K; Sobrian SK
Neurotoxicol Teratol; 2008; 30(4):288-325. PubMed ID: 18280700
[TBL] [Abstract][Full Text] [Related]
6. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
7. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
[TBL] [Abstract][Full Text] [Related]
8. Strategy for genotoxicity testing--metabolic considerations.
Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
[TBL] [Abstract][Full Text] [Related]
9. Introduction to the ILSI Research Foundation/Risk Science Institute reports from the expert working group on neurodevelopmental endpoints.
Fitzpatrick J; Mendez E; Walls I
Neurotoxicol Teratol; 2008; 30(4):263-5. PubMed ID: 18407461
[TBL] [Abstract][Full Text] [Related]
10. Research strategy for developing key information on bromate's mode of action.
Bull RJ; Cottruvo JA
Toxicology; 2006 Apr; 221(2-3):135-44. PubMed ID: 16298034
[TBL] [Abstract][Full Text] [Related]
11. A critical evaluation of developmental and reproductive toxicology in nonhuman primates.
Faqi AS
Syst Biol Reprod Med; 2012 Feb; 58(1):23-32. PubMed ID: 22239078
[TBL] [Abstract][Full Text] [Related]
12. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Holson RR; Freshwater L; Maurissen JP; Moser VC; Phang W
Neurotoxicol Teratol; 2008; 30(4):326-48. PubMed ID: 17681748
[TBL] [Abstract][Full Text] [Related]
13. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
14. Improving toxicity screening and drug development by using genetically defined strains.
Festing MF
Methods Mol Biol; 2010; 602():1-21. PubMed ID: 20012389
[TBL] [Abstract][Full Text] [Related]
15. Developmental and reproductive toxicology studies in nonhuman primates.
Chellman GJ; Bussiere JL; Makori N; Martin PL; Ooshima Y; Weinbauer GF
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):446-62. PubMed ID: 20025046
[TBL] [Abstract][Full Text] [Related]
16. Pre- and postnatal developmental toxicity study design for pharmaceuticals.
Bailey GP; Wise LD; Buschmann J; Hurtt M; Fisher JE
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):437-45. PubMed ID: 20025040
[TBL] [Abstract][Full Text] [Related]
17. The concept of multispecies testing in industrial toxicology.
Zbinden G
Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
[TBL] [Abstract][Full Text] [Related]
18. Current developments in reproductive toxicity testing of pesticides.
Cooper RL
Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482
[TBL] [Abstract][Full Text] [Related]
19. Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Tyl RW; Crofton K; Moretto A; Moser V; Sheets LP; Sobotka TJ
Neurotoxicol Teratol; 2008; 30(4):349-81. PubMed ID: 17826946
[TBL] [Abstract][Full Text] [Related]
20. Juvenile animal toxicity study designs to support pediatric drug development.
Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
